||Wednesday April 25, 2018 1:00 pm to 3:00 pm
||Aging, Dementia, Cognitive, and Behavioral Neurology, Foundations in Clinical Neurology
||Gil Rabinovici MD
||Frontotemporal dementia (FTD) defines a family of disorders that are characterized clinically by progressive changes in social-emotional function (behavioral-variant, bvFTD) or language (non-fluent/agrammatic or semantic variants of primary progressive aphasia, PPA), in the setting of degeneration of the frontal and anterior temporal lobes. FTD is as common as Alzheimer's disease (AD) in patients presenting with an early-onset dementia (under age 65), and familiarity with the syndromes can help neurologists advise on heritability, prognosis and appropriate treatment. Faculty will present a case-based approach to introduce the diverse clinical presentations of these disorders, and provide an update on biomarker development and advances in understanding the genetic and molecular underpinnings of these disorders.
This program complements C161: Non-Alzheimer's Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias, but covers independent topics.
||Participants should be able to apply up-to-date clinical criteria and diagnostic tools to classify the different subtypes of bvFTD and PPA, and differentiate these disorders from atypical presentations of AD. Improving clinical diagnosis and in vivo prediction of molecular pathology is critical in preparation for emerging disease-specific therapies for these disorders.
||Medical Knowledge, Patient Care